Men & Women Welcome To Participate In This Cyclosporine & IC Study

If you are suffering from Interstitial Cystitis (Painful Bladder Syndrome) and have had three or more failed therapies, you may be a candidate for “Cyclosporine in Interstitial Cystitis” study at the Cleveland Clinic. Several research studies have been published showing that Cyclosporine can improve the symptoms of Interstitial Cystitis. It is a government funded study and can be found in

You may be eligible if you:

  • Are over the age of 18 years.
  • Have been diagnosed with Interstitial Cystitis.
  • Have failed a minimum of three therapies.

Exclusion Criteria:

  • Active Cancer, pelvic radiation, previous urological cancer.
  • Diabetes, serum Creatinine > 1.5 mg/dL, untreated proteinuria, untreated UTI, allergy to iodine, hypersensitivity to cyclosporine.
  • Chronic use of opioid therapy, medication impacting cyclosporine, immunosuppressive medication.
  • Pregnant or breast feeding
  • Urinary diversion or bladder augmentation,
  • Pacemaker.

Location & Duration:

The study involves 4 – 5 visits at 1 month intervals with compensation of $50 for 4 visits. The study location is:

Cleveland Clinic

Cleveland Clinic
Glickman Urological and Kidney Institute
2050 East 96th Street
Cleveland, OH 44195

If interested and/or to learn more, please contact:

Barbara Tucky, MBA, Study Coordinator